170 related articles for article (PubMed ID: 37952244)
21. Cardiovascular Risk Factors in Survivors of Childhood Hematopoietic Cell Transplantation Treated with Total Body Irradiation: A Longitudinal Analysis.
Friedman DN; Hilden P; Moskowitz CS; Suzuki M; Boulad F; Kernan NA; Wolden SL; Oeffinger KC; Sklar CA
Biol Blood Marrow Transplant; 2017 Mar; 23(3):475-482. PubMed ID: 28040534
[TBL] [Abstract][Full Text] [Related]
22. Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women.
Arsenault BJ; Rana JS; Stroes ES; Després JP; Shah PK; Kastelein JJ; Wareham NJ; Boekholdt SM; Khaw KT
J Am Coll Cardiol; 2009 Dec; 55(1):35-41. PubMed ID: 20117361
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of lipid abnormalities in the United States: the National Health and Nutrition Examination Survey 2003-2006.
Tóth PP; Potter D; Ming EE
J Clin Lipidol; 2012; 6(4):325-30. PubMed ID: 22836069
[TBL] [Abstract][Full Text] [Related]
24. Triglyceride and HDL-C Dyslipidemia and Risks of Coronary Heart Disease and Ischemic Stroke by Glycemic Dysregulation Status: The Strong Heart Study.
Lee JS; Chang PY; Zhang Y; Kizer JR; Best LG; Howard BV
Diabetes Care; 2017 Apr; 40(4):529-537. PubMed ID: 28122840
[TBL] [Abstract][Full Text] [Related]
25. Long-term risk of cardiovascular events across a spectrum of adverse major plasma lipid combinations in the Framingham Heart Study.
Andersson C; Lyass A; Vasan RS; Massaro JM; D'Agostino RB; Robins SJ
Am Heart J; 2014 Dec; 168(6):878-83.e1. PubMed ID: 25458651
[TBL] [Abstract][Full Text] [Related]
26. Improvement in liver histology is associated with reduction in dyslipidemia in children with nonalcoholic fatty liver disease.
Corey KE; Vuppalanchi R; Vos M; Kohli R; Molleston JP; Wilson L; Unalp-Arida A; Cummings OW; Lavine JE; Chalasani N;
J Pediatr Gastroenterol Nutr; 2015 Mar; 60(3):360-7. PubMed ID: 25714579
[TBL] [Abstract][Full Text] [Related]
27. Impact of diabetes, high triglycerides and low HDL cholesterol on risk for ischemic cardiovascular disease varies by LDL cholesterol level: a 15-year follow-up of the Chinese Multi-provincial Cohort Study.
Liu J; Wang W; Wang M; Sun J; Liu J; Li Y; Qi Y; Wu Z; Zhao D
Diabetes Res Clin Pract; 2012 May; 96(2):217-24. PubMed ID: 22244364
[TBL] [Abstract][Full Text] [Related]
28. Is non-HDL-cholesterol a better predictor of long-term outcome in patients after acute myocardial infarction compared to LDL-cholesterol? : a retrospective study.
Wongcharoen W; Sutthiwutthichai S; Gunaparn S; Phrommintikul A
BMC Cardiovasc Disord; 2017 Jan; 17(1):10. PubMed ID: 28056802
[TBL] [Abstract][Full Text] [Related]
29. Risk of Cardiovascular Events in Patients With Type 2 Diabetes and Metabolic Dyslipidemia Without Prevalent Atherosclerotic Cardiovascular Disease.
Rana JS; Liu JY; Moffet HH; Sanchez RJ; Khan I; Karter AJ
Am J Med; 2020 Feb; 133(2):200-206. PubMed ID: 31344341
[TBL] [Abstract][Full Text] [Related]
30. Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: the National Health and Nutrition Examination Survey 2003-2004.
Ghandehari H; Kamal-Bahl S; Wong ND
Am Heart J; 2008 Jul; 156(1):112-9. PubMed ID: 18585505
[TBL] [Abstract][Full Text] [Related]
31. Appropriate Total cholesterol cut-offs for detection of abnormal LDL cholesterol and non-HDL cholesterol among low cardiovascular risk population.
Nantsupawat N; Booncharoen A; Wisetborisut A; Jiraporncharoen W; Pinyopornpanish K; Chutarattanakul L; Angkurawaranon C
Lipids Health Dis; 2019 Jan; 18(1):28. PubMed ID: 30684968
[TBL] [Abstract][Full Text] [Related]
32. Twenty-first century epidemiology of dyslipidemia in Greece: EMENO national epidemiological study.
Stergiou GS; Ntineri A; Menti A; Kalpourtzi N; Vlachopoulos C; Liberopoulos EN; Rallidis L; Richter D; Gavana M; Vantarakis A; Chlouverakis G; Hajichristodoulou C; Trypsianis G; Voulgari PV; Alamanos Y; Karakosta A; Touloumi G
Hellenic J Cardiol; 2023; 69():1-8. PubMed ID: 36243397
[TBL] [Abstract][Full Text] [Related]
33. Long-term prognostic value of LDL-C, HDL-C, lp(a) and TG levels on cardiovascular disease incidence, by body weight status, dietary habits and lipid-lowering treatment: the ATTICA epidemiological cohort study (2002-2012).
Georgoulis M; Chrysohoou C; Georgousopoulou E; Damigou E; Skoumas I; Pitsavos C; Panagiotakos D
Lipids Health Dis; 2022 Dec; 21(1):141. PubMed ID: 36529737
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of combined and noncombined dyslipidemia in an Iranian population.
Darroudi S; Saberi-Karimian M; Tayefi M; Arekhi S; Motamedzadeh Torghabeh A; Seyedzadeh Sani SMR; Moohebati M; Heidari-Bakavoli A; Ebrahimi M; Azarpajouh MR; Safarian M; A Ferns G; Esmaeili H; Parizadeh MR; Mokhber N; Mahdizadeh A; Mahmoudi AA; Sahebkar AH; Ghayour-Mobarhan M
J Clin Lab Anal; 2018 Oct; 32(8):e22579. PubMed ID: 29926995
[TBL] [Abstract][Full Text] [Related]
35. The role of niacin in raising high-density lipoprotein cholesterol to reduce cardiovascular events in patients with atherosclerotic cardiovascular disease and optimally treated low-density lipoprotein cholesterol: baseline characteristics of study participants. The Atherothrombosis Intervention in Metabolic syndrome with low HDL/high triglycerides: impact on Global Health outcomes (AIM-HIGH) trial.
AIM-HIGH Investigators
Am Heart J; 2011 Mar; 161(3):538-43. PubMed ID: 21392609
[TBL] [Abstract][Full Text] [Related]
36. Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies.
Ray KK; Del Prato S; Müller-Wieland D; Cariou B; Colhoun HM; Tinahones FJ; Domenger C; Letierce A; Mandel J; Samuel R; Bujas-Bobanovic M; Leiter LA
Cardiovasc Diabetol; 2019 Nov; 18(1):149. PubMed ID: 31706300
[TBL] [Abstract][Full Text] [Related]
37. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.
Jellinger PS; Handelsman Y; Rosenblit PD; Bloomgarden ZT; Fonseca VA; Garber AJ; Grunberger G; Guerin CK; Bell DSH; Mechanick JI; Pessah-Pollack R; Wyne K; Smith D; Brinton EA; Fazio S; Davidson M
Endocr Pract; 2017 Apr; 23(Suppl 2):1-87. PubMed ID: 28437620
[TBL] [Abstract][Full Text] [Related]
38. Apolipoprotein B, Triglyceride-Rich Lipoproteins, and Risk of Cardiovascular Events in Persons with CKD.
Lamprea-Montealegre JA; Staplin N; Herrington WG; Haynes R; Emberson J; Baigent C; de Boer IH;
Clin J Am Soc Nephrol; 2020 Jan; 15(1):47-60. PubMed ID: 31831577
[TBL] [Abstract][Full Text] [Related]
39. Long term survivors of childhood brain cancer have an increased risk for cardiovascular disease.
Heikens J; Ubbink MC; van der Pal HP; Bakker PJ; Fliers E; Smilde TJ; Kastelein JJ; Trip MD
Cancer; 2000 May; 88(9):2116-21. PubMed ID: 10813724
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]